Perimeter Medical Imaging AI (TSE:PINK) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Perimeter Medical Imaging AI has completed patient enrollment for a key clinical trial of its OCT B-Series system, which utilizes AI with optical coherence tomography to potentially lower reoperation rates in breast-conserving surgeries. The technology aims to improve margin assessment during surgery, with hopes that success in the trial could lead to FDA submission by 2025.
For further insights into TSE:PINK stock, check out TipRanks’ Stock Analysis page.
